Laddha Ankit P, Chawda Mukesh B, Kulkarni Yogesh A
Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM's NMIMS, V.L. Mehta Road, Vile Parle (West), Mumbai, 400056 India.
Shree Dhootapapeshwar Limited, 135, Nanubhai Desai Road, Khetwadi Mumbai, 400 004 India.
J Diabetes Metab Disord. 2022 Mar 18;21(2):1261-1270. doi: 10.1007/s40200-022-01012-4. eCollection 2022 Dec.
Ayurvedic system, a traditional medicinal system has mentioned a preparation Bruhat Vata Chintamani Rasa (Suvarnayukta) for management of heart diseases Hrudroga Chintamani Rasa (HCR) is a formulation containing Bruhat Vata Chintamani Rasa and a few additional ingredients having beneficial effects in heart diseases. The present study was designed to investigate the cardioprotective activity of the Hrudroga Chintamani Rasa in isoproterenol (ISO)-induced myocardial infarction in rats.
Male Sprague Dawley rats were treated with HCR at a dose of 56.16 and 112.32 mg/kg for 30 days. Animals received ISO (85 mg/kg. ) on 28th and 29th day at an interval of 24 h.
Disease control animals treated with HCR at a dose of 56.16 mg/kg and 112.32 mg/kg to rats showed a significant reduction in elevated levels of aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and creatine phosphokinase MB (CK-MB), and prevented loss of depleted antioxidant enzymes from the cardiac tissue. ISO-altered electrocardiogram pattern and haemodynamic parameters were also brought about to normal by treatment with HCR. HCR treatment also improved the levels of 5' adenosine monophosphate-activated protein kinase (AMPK) and Silent information regulator 1 (SIRT1) which have potent role in antioxidant defence mechanism. Histopathological findings also showed HCR treatment prevented cardiac tissue from damage.
HCR treatment showed a significant cardioprotective effect in ISO-induced cardiotoxicity in rats probably because of the potent antioxidant activity.
The online version contains supplementary material available at 10.1007/s40200-022-01012-4.
阿育吠陀体系,一种传统医学体系,提及了一种用于治疗心脏病的制剂——大补风醒脑珍珠丸(含苏合香)。心脏病醒脑珍珠丸(HCR)是一种包含大补风醒脑珍珠丸和其他一些对心脏病有有益作用成分的配方。本研究旨在探讨心脏病醒脑珍珠丸对异丙肾上腺素(ISO)诱导的大鼠心肌梗死的心脏保护作用。
雄性斯普拉格-道利大鼠分别以56.16和112.32毫克/千克的剂量给予HCR治疗30天。动物在第28天和第29天每隔24小时接受ISO(85毫克/千克)。
以56.16毫克/千克和112.32毫克/千克剂量给予大鼠HCR治疗的疾病对照动物,其天冬氨酸转氨酶(AST)、乳酸脱氢酶(LDH)和肌酸磷酸激酶MB(CK-MB)升高水平显著降低,并防止了心脏组织中消耗的抗氧化酶的损失。HCR治疗还使ISO改变的心电图模式和血流动力学参数恢复正常。HCR治疗还提高了在抗氧化防御机制中起重要作用的5'-单磷酸腺苷激活蛋白激酶(AMPK)和沉默信息调节因子1(SIRT1)的水平。组织病理学结果也显示HCR治疗可防止心脏组织受损。
HCR治疗对ISO诱导的大鼠心脏毒性具有显著的心脏保护作用,可能是由于其强大的抗氧化活性。
在线版本包含可在10.1007/s40200-022-01012-4获取的补充材料。